|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.640 USD | +11.27% |
|
+16.58% | +16.00% |
| Market Cap | 460M 398M 372M 341M 641M 43.78B 651M 4.36B 1.71B 21.95B 1.73B 1.69B 72.55B | P/E 2026 * |
-7.12x | P/E 2027 * | -6.71x |
|---|---|---|---|---|---|
| Enterprise Value | 369M 319M 298M 274M 515M 35.14B 523M 3.5B 1.37B 17.61B 1.39B 1.36B 58.23B | EV / Sales 2026 * |
24.6x | EV / Sales 2027 * | 23x |
| Free-Float |
87.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: X4 Pharmaceuticals, Inc.
| 1 day | +11.27% | ||
| 1 week | +16.58% | ||
| Current month | +16.58% | ||
| 1 month | +17.17% | ||
| 3 months | +4.74% | ||
| 6 months | +30.34% | ||
| Current year | +16.00% |
| 1 week | 3.96 |  | 4.82 |
| 1 month | 3.56 | | 4.82 |
| Current year | 2.83 | | 4.83 |
| 1 year | 1.35 | | 4.83 |
| 3 years | 1.35 | | 48 |
| 5 years | 1.35 | | 186.3 |
| 10 years | 1.35 | | 717.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 60 | - |
David Kirske
DFI | Director of Finance/CFO | 71 | 2025-08-11 |
John Volpone
PSD | President | - | 2025-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Wyzga
CHM | Chairman | 71 | 2018-06-30 |
Gary Bridger
BRD | Director/Board Member | 63 | 2018-09-30 |
Murray Stewart
BRD | Director/Board Member | 65 | 2019-03-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 110,000 | 0.1166% | ||
| 6/30/26 | Sell | Chief Financial Officer | -8,543 | 0.0091% | ||
| 1/1/26 | Free | Director | 110,000 | 0.1258% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.27% | +16.58% | +211.41% | -90.85% | 438M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +2.15% | +2.44% | +51.52% | +30.79% | 362.12B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.74% | +64.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.98M 12.96M 12.1M 11.1M 20.88M 1.43B 21.21M 142M 55.72M 715M 56.25M 55.02M 2.36B | 11.56M 10M 9.34M 8.57M 16.11M 1.1B 16.37M 110M 43M 551M 43.41M 42.46M 1.82B |
| Net income | -84.82M -73.37M -68.52M -62.85M -118M -8.07B -120M -804M -316M -4.05B -319M -312M -13.38B | -98.9M -85.55M -79.89M -73.29M -138M -9.41B -140M -937M -368M -4.72B -371M -363M -15.6B |
| Net Debt | -90.8M -78.54M -73.35M -67.28M -127M -8.64B -129M -861M -338M -4.33B -341M -334M -14.32B | -194M -168M -157M -144M -270M -18.46B -275M -1.84B -722M -9.25B -729M -713M -30.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$4.640 | +11.27% | 1,597,331 |
| 26-08-06 | US$4.170 | +0.48% | 447,777 |
| 26-08-05 | US$4.150 | -3.26% | 372,617 |
| 26-08-04 | US$4.290 | +4.89% | 604,731 |
| 26-08-03 | US$4.090 | +2.76% | 364,079 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- XFOR Stock
Select your edition
All financial news and data tailored to specific country editions
